167 related articles for article (PubMed ID: 27259306)
21. Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies.
Harding SJ; Mead GP; Bradwell AR; Berard AM
Clin Chem Lab Med; 2009; 47(3):302-4. PubMed ID: 19676141
[TBL] [Abstract][Full Text] [Related]
22. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.
Milani P; Murray DL; Barnidge DR; Kohlhagen MC; Mills JR; Merlini G; Dasari S; Dispenzieri A
Am J Hematol; 2017 Aug; 92(8):772-779. PubMed ID: 28439985
[TBL] [Abstract][Full Text] [Related]
23. Performance comparison of EasyFix G26 and HYDRASYS 2 SCAN for the detection of serum monoclonal proteins.
Amin Nordin FD; Mohd Khalid MKN; Abdul Aziz SM; Mohamad Bakri NA; Ahmad Ridzuan SN; Abdul Jalil J; Habib A; Yakob Y
J Clin Lab Anal; 2020 Jun; 34(6):e23254. PubMed ID: 32141626
[TBL] [Abstract][Full Text] [Related]
24. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
25. Analytical sensitivity and diagnostic performance of serum protein electrophoresis on the HYDRAGEL 30 PROTEIN(E) β1-β2 Sebia Hydrasys system.
Tsui AKY; Thomas D; Hunt A; Estey M; Christensen CL; Higgins T; Sandhu I; Rodriguez-Capote K
Clin Biochem; 2018 Jan; 51():80-84. PubMed ID: 28916438
[TBL] [Abstract][Full Text] [Related]
26. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.
Sanchorawala V; Seldin DC; Magnani B; Skinner M; Wright DG
Bone Marrow Transplant; 2005 Oct; 36(7):597-600. PubMed ID: 16044137
[TBL] [Abstract][Full Text] [Related]
27. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G
Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852
[TBL] [Abstract][Full Text] [Related]
28. Is urine immunofixation electrophoresis necessary for monitoring myeloma patients who have undergone hematopoietic stem cell transplantation?
Sencar ME; Yıldız A; Haznedar R
Transfus Apher Sci; 2019 Dec; 58(6):102660. PubMed ID: 31734164
[TBL] [Abstract][Full Text] [Related]
29. Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors.
Sureddi RK; Amani F; Hebbar P; Williams DK; Leonardi M; Paydak H; Mehta JL
Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):229-36. PubMed ID: 23047326
[TBL] [Abstract][Full Text] [Related]
30. Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma.
Barley K; Tindle S; Bagiella E; Jagannath S; Chari A
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):541-5. PubMed ID: 26119495
[TBL] [Abstract][Full Text] [Related]
31. Audit of the Prevalence of Noncorrelation of Immunofixation with Protein Electrophoresis and Serum Free Light Chain Assays in Multiple Myeloma in a Tertiary Cancer Care Center.
Paul C; Chakraborty S; Sugumar S; Bhattacharya R; Rath S; Chakraborty S
Indian J Clin Biochem; 2021 Jul; 36(3):353-359. PubMed ID: 34220011
[TBL] [Abstract][Full Text] [Related]
32. The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.
Pratt G; Mead GP; Godfrey KR; Hu Y; Evans ND; Chappell MJ; Lovell R; Bradwell AR
Leuk Lymphoma; 2006 Jan; 47(1):21-8. PubMed ID: 16321823
[TBL] [Abstract][Full Text] [Related]
33. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
34. Identification of M protein from filter paper using serum protein and immunofixation electrophoresis.
Wu Y; Yang X; Wang T; Wang H; Li Z
Am J Clin Pathol; 2012 Oct; 138(4):604-8. PubMed ID: 23010716
[TBL] [Abstract][Full Text] [Related]
35. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
van de Donk NW; Otten HG; El Haddad O; Axel A; Sasser AK; Croockewit S; Jacobs JF
Clin Chem Lab Med; 2016 Jun; 54(6):1105-9. PubMed ID: 26812873
[TBL] [Abstract][Full Text] [Related]
36. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
Mösbauer U; Ayuk F; Schieder H; Lioznov M; Zander AR; Kröger N
Haematologica; 2007 Feb; 92(2):275-6. PubMed ID: 17296589
[TBL] [Abstract][Full Text] [Related]
37. Is accuracy of serum free light chain measurement achievable?
Jacobs JF; Tate JR; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1021-30. PubMed ID: 26641970
[TBL] [Abstract][Full Text] [Related]
38. [Detection of free light chains--a new method of diagnostics of haematological diseases].
Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
[TBL] [Abstract][Full Text] [Related]
39. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
[TBL] [Abstract][Full Text] [Related]
40. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay.
Rosenberg AS; Bainbridge S; Pahwa R; Jialal I
Clin Biochem; 2016 Oct; 49(15):1202-1204. PubMed ID: 27475249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
